BB

Brent Blackburn

CT Cv Therapeutics: 10 patents #9 of 71Top 15%
Genentech: 10 patents #288 of 2,392Top 15%
GS Gilead Sciences: 3 patents #394 of 952Top 45%
GA Gilead Palo Alto: 1 patents #18 of 28Top 65%
📍 San Francisco, CA: #1,472 of 26,999 inventorsTop 6%
🗺 California: #23,010 of 386,348 inventorsTop 6%
Overall (All Time): #174,601 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
9163057 Methods of myocardial perfusion imaging Luiz Belardinelli, Zhenhai Gao 2015-10-20
8536150 Methods of myocardial perfusion imaging Luiz Belardinelli, Zhenhai Gao 2013-09-17
8071566 Methods of coronary imaging Luiz Belardinelli, Zhenhai Gao 2011-12-06
7776868 Substituted bicyclic and tricyclic thieno[2,3-d]pyrimidines as A2A adenosine receptor antagonists Tetsuya Kobayashi, Rao V. Kalla, Elfatih Elzein, Jeff Zablocki 2010-08-17
7582617 Myocardial perfusion imaging method Luiz Belardinelli, Zhenhai Gao 2009-09-01
7109326 Halo-alkoxycarbonyl prodrugs Alan G. Olivero, Kirk Robarge 2006-09-19
6852723 Aralkyl substituted piperazine compounds Jeff Zablocki, Elfatih Elzein, Tim Marquart, Prabha N. Ibrahim, Venkata P. Palle 2005-02-08
6677336 Substituted piperazine compounds Jeff Zablocki, Elfatih Elzein, Grigory Nudelman, Tim Marquart, Venkata P. Palle 2004-01-13
6677342 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure Andrew Wolff, Hani N. Sabbah, William Clark Stanley 2004-01-13
6677343 Substituted piperazine compounds Jeff Zablocki, Elfatih Elzein, Grigory Nudelman 2004-01-13
6599283 Method of preventing reperfusion injury Mario Marzilli 2003-07-29
6576619 Orally active A1 adenosine receptor agonists Chris Melville, Jeff Zablocki, Venkata P. Palle, Elfaith Elzein, Lisa Wang 2003-06-10
6552023 Aralkyl substituted piperazine compounds Jeff Zablocki, Elfatih Elzein, Tim Marquart, Prabha N. Ibrahim, Venkata P. Palle 2003-04-22
6528511 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure Andrew Wolff, Hani N. Sabbah, William Clark Stanley 2003-03-04
6451798 Substituted alkyl piperazine derivatives Vaibhav Varkhedkar, Venkata P. Palle, Jeff Zablocki, Elfatih Elzein 2002-09-17
5716951 Tricyclic inhibitors of the vitronectin receptor Kirk Robarge, Todd C. Somers 1998-02-10
5705890 Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor Kirk Robarge, Todd C. Somers 1998-01-06
5674863 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee, Todd C. Somers +2 more 1997-10-07
5674865 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee, Todd C. Somers +2 more 1997-10-07
5663166 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee, Todd C. Somers +2 more 1997-09-02
5565449 Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee, Todd C. Somers +2 more 1996-10-15
5493020 Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor Kirk Robarge, Todd C. Somers 1996-02-20
5403836 Benzazepine platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub.a receptor Robert McDowell, Thomas Gadek, Rob Webb 1995-04-04
5250679 Nonpeptidyl platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub. receptor Robert McDowell, Thomas Gadek, Peter L. Barker, Lawrence R. McGee, Rob Webb 1993-10-05